Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Parasite Immunol ; 43(6): e12826, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33586210

RESUMEN

BACKGROUND: Extract of adult Ascaris suum (ASC) worms attenuated the liver damage in experimental autoimmune hepatitis (EAH) with induction of Th2 immune response, but fibrosis occurred. N-acetyl-L-cysteine (NAC) has protective effects against liver fibrosis. OBJECTIVES: Evaluate the association ASC + NAC on the T- and B-cell activation, inflammation and fibrogenic markers in the liver in EAH. METHODS: Experimental autoimmune hepatitis was induced intravenously with concanavalin A in BALB/c mice. EAH + ASC+NAC group received NAC and ASC; EAH + ASC group received ASC; EAH group received PBS. Doubly labelled CD4+ T (CD28, CTLA-4, CD40L or IL-10) and CD45R+ B lymphocytes (IL-10) and CD4+ CD25+ FoxP3+ cells were evaluated, along with gene expression of Col1a1, α-SMA, Fizz1, Arg1 and PPAR-γ and histomorphometry. RESULTS: Experimental autoimmune hepatitis group showed high frequency of CD28+ and CD40L+  T lymphocytes, but not the EAH + ASC group. In relation to EAH group, the Fizz1 expression was lower in both groups treated, but Arg1 expression was lower in only EAH + ASC+NAC group. In the EAH + ASC+NAC group, there were higher frequencies of CD4+ IL-10+ and CD4+ CD25+ FoxP3+ cells, but not CD45R+ IL-10+ , along with mitigated inflammation and collagen production. CONCLUSIONS: Ascaris suum favoured immunosuppression in EAH limiting the T cells activation. However, association ASC and NAC was necessary for attenuating the inflammatory process and collagen production.


Asunto(s)
Ascaris suum , Hepatitis Autoinmune , Acetilcisteína , Animales , Hepatitis Autoinmune/tratamiento farmacológico , Inmunosupresores , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales , Linfocitos T Reguladores
2.
Phytomedicine ; 21(3): 261-7, 2014 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-24090700

RESUMEN

The activity of ß-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione, ß-lap) against different stages of Schistosoma mansoni was investigated in mice. Mice infected with 50 cercariae (BH strain) were intraperitoneally treated at a dose of 50 mg/kg for 5 consecutive days, starting on the 1st, 14th, 28th and 45th days after infection, to evaluate the effect of ß-lap on skin schistosomula, lung schistosomula, young worms (before oviposition) and adult worms (after oviposition), respectively. All animals were euthanized 60 days after infection. ß-Lap significantly reduced (p<0.001) the number of worms in 29.78%, 37.2%, 24.2% and 40.22% when administered during the phases of skin schistosomula, lung schistosomula, young worms and adult worms, respectively. Significant reduction was also achieved in terms of female burden. In all groups, there was significant reduction in the number of eggs and granulomas in the hepatic tissue. When the intervention was performed during the phase of adult worms, ß-lap reduced the size of hepatic granulomas and changed the oogram pattern, lowering the percentage of immature eggs and increasing the percentage of mature and dead eggs. Our data indicate that ß-lap has moderate antischistosomal properties. Its molecule may also be used as a prototype for synthesis of new naphthoquinone derivatives with potential schistosomicidal properties. Further studies with different formulations containing ß-lap are needed to clearly establish the best dose and route of administration and its mechanism of action against schistosomes.


Asunto(s)
Hepatopatías/tratamiento farmacológico , Enfermedades Pulmonares/tratamiento farmacológico , Naftoquinonas/uso terapéutico , Fitoterapia , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/tratamiento farmacológico , Enfermedades de la Piel/tratamiento farmacológico , Animales , Antiparasitarios/farmacología , Antiparasitarios/uso terapéutico , Femenino , Granuloma , Estadios del Ciclo de Vida , Hígado/parasitología , Hepatopatías/parasitología , Hepatopatías/patología , Pulmón/parasitología , Enfermedades Pulmonares/parasitología , Magnoliopsida/química , Ratones , Naftoquinonas/farmacología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Schistosoma mansoni/crecimiento & desarrollo , Esquistosomiasis mansoni/parasitología , Esquistosomiasis mansoni/patología , Piel/parasitología , Enfermedades de la Piel/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA